Skip to content
ApprovedFDA approved

Ezetimibe (Ezetrol, Zetia)

Prescription cholesterol-lowering medicine that blocks cholesterol absorption in the intestine; can also be used with a statin.

Available at
DEUSPOWER logo
DEUSPOWERProduct page

The links above are labelled third-party affiliate links. MolekulaX does not sell and does not verify product quality.

Ezetimibe (Ezetrol, Zetia) vial

DETAILED OVERVIEW

What is Ezetimibe (Ezetrol, Zetia)?

Ezetimibe, also sold as Ezetrol and Zetia, is a prescription cholesterol-lowering medicine. It is approved for high cholesterol, either on its own or together with a statin (another class of cholesterol-lowering drugs).

In the small intestine it blocks cholesterol from being absorbed from food and bile. On its own it lowers LDL (the “bad” cholesterol) by about 15–20%, which is modest, but it acts independently of statins, so the two effects add up. In a large trial, adding it to a statin after an acute heart problem led to fewer cardiovascular events. It was the first non-statin drug shown to have this benefit. It can cause digestive complaints and a mild, temporary rise in liver enzymes; muscle pain occurs mainly together with a statin. It must not be used in pregnancy or breastfeeding, or in active liver disease. With a medicine called ciclosporin it can be given only under close monitoring, because the two raise each other’s levels.

Mechanism

NPC1L1 inhibition in the small intestine: blocks absorption of dietary and biliary cholesterol.

LDL reduction

About 15-20% as monotherapy; a further substantial fall on top of a statin, because the target is independent.

Why it is a milestone

The first non-statin LDL-lowering drug with proven cardiovascular benefit

Bioavailability

Cannot be determined in absolute terms, as the compound is practically insoluble in aqueous media.

Data console

Lab data

ATC code-
PrescriptionN/A
MechanismIn the brush border of enterocytes, the NPC1L1 protein is…
Half-lifeThe active glucuronide metabolite has a half-life of about 22 hours, which permits once-daily dosing. The compound undergoes enterohepatic recirculation, so its action at the intestinal level is sustained.
OnsetA fall in lipid levels is measurable within two weeks, with the full effect developing over roughly four weeks.
BioavailabilityAbsolute bioavailability cannot be determined, because ezetimibe is practically insoluble in aqueous media and no intravenous comparator formulation can be prepared. It is rapidly absorbed and immediately converted in the intestinal wall to an active glucuronide; that metabolite also inhibits NPC1L1 and returns repeatedly to the site of action through enterohepatic recirculation.

Safety

Side effects, stop signs, contraindications

Side effects · 4

  • Muscle pain: more frequent in combination with a statin, while as monotherapy it barely differed from placebo in trials. This is one reason it is considered an alternative in statin intolerance.
  • Rising liver enzymes: usually mild and transient, more frequent in combination with a statin than alone.
  • Gastrointestinal complaints: diarrhea, bloating, abdominal discomfort. Mild and usually improving with continued treatment.
  • Fatigue: a less common complaint, but listed in the Florentin 2008 clinician-facing review of adverse effects.

Contraindications · 4

  • Active liver disease or persistent unexplained transaminase elevation: must be clarified before starting treatment.
  • Pregnancy and breastfeeding: cholesterol is essential to fetal development, so lipid-lowering treatment is contraindicated.
  • In combination with a statin the statin's own contraindications apply: active liver disease, pregnancy, and the statin's own interactions.
  • Ciclosporin therapy: the two raise each other's plasma levels, so co-administration requires close monitoring.

Related Pharmaceuticals

Same therapeutic category

Studies

Related research and clinical findings

Telegram

Have a question about Ezetimibe (Ezetrol, Zetia)?

Educational drug info from official sources (PubMed, FDA, EMA). Does NOT replace medical consultation or the SmPC. Talk to your doctor!

Personalized consultation

Want a detailed conversation tailored to your data?

Fill out the prep intake form (your goals, training and health data), and the advisor prepares from it to give genuinely personalized guidance.

Fill out the form

~5–7 min · prep questionnaire · confidential · GDPR-compliant

MolekulaX Editorial Team·Source-verified · PubMed · FDA · EMA
Updated: October 14, 2026

The information here is for educational and scientific purposes only. Medication use requires medical consultation and a prescription. The indications, dose ranges, and side effects listed here do NOT replace the official Summary of Product Characteristics (SmPC) or consultation with a physician. Do not start or stop any medication on your own. In an emergency, call your local emergency number.